|
TSR-042 or Dostarlimab Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Dostarlimab
Hartford, Connecticut1 trial
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Hartford Healthcare (Data Collection)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.